Hasini Jayatilaka, left, a post-doctoral fellow and Denis Wirtz, professor of chemical and biomedical engineering, who work together at the Institute of NanoBioTechnology at Johns Hopkins University, discuss their discovery that a biochemical signaling process that causes the spread of cancer cells can be slowed down with the use of two existing drugs.
Hasini Jayatilaka, left, a post-doctoral fellow and Denis Wirtz, professor of chemical and biomedical engineering, who work together at the Institute of NanoBioTechnology at Johns Hopkins University, discuss their discovery that a biochemical signaling process that causes the spread of cancer cells can be slowed down with the use of two existing drugs. Amy Davis TNS
Hasini Jayatilaka, left, a post-doctoral fellow and Denis Wirtz, professor of chemical and biomedical engineering, who work together at the Institute of NanoBioTechnology at Johns Hopkins University, discuss their discovery that a biochemical signaling process that causes the spread of cancer cells can be slowed down with the use of two existing drugs. Amy Davis TNS

Researchers say they’ve unlocked key to cancer metastasis and how to slow it

June 19, 2017 12:10 PM

UPDATED June 19, 2017 12:11 PM

More Videos

  • First treatment that genetically modifies patients’ cells to destroy cancer approved by FDA

    T-cells are one of immune system’s key soldiers, targeting infected or abnormal cells but cancer can block those defenses Now scientists are genetically modifying patients own cells to make them smarter and tougher at seeking out and destroying cancer. One version is called CAR-T cell therapy, T-cells customized to zero in on a patients specific kind of cancer.